334 related articles for article (PubMed ID: 17912445)
21. A potent replicative delta-24 adenoviral vector driven by the promoter of human papillomavirus 16 that is highly selective for associated neoplasms.
Delgado-Enciso I; Cervantes-García D; Martínez-Dávila IA; Ortiz-López R; Alemany-Bonastre R; Silva-Platas CI; Lugo-Trampe A; Barrera-Saldaña HA; Galván-Salazar HR; Coronel-Tene CG; Sánchez-Santillán CF; Rojas-Martínez A
J Gene Med; 2007 Oct; 9(10):852-61. PubMed ID: 17729237
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional targeting of tumors with a novel tumor-specific survivin promoter.
Zhu ZB; Makhija SK; Lu B; Wang M; Kaliberova L; Liu B; Rivera AA; Nettelbeck DM; Mahasreshti PJ; Leath CA; Barker S; Yamaoto M; Li F; Alvarez RD; Curiel DT
Cancer Gene Ther; 2004 Apr; 11(4):256-62. PubMed ID: 15017380
[TBL] [Abstract][Full Text] [Related]
23. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis.
Li X; Jung C; Liu YH; Bae KH; Zhang YP; Zhang HJ; Vanderputten D; Jeng MH; Gardner TA; Kao C
J Gene Med; 2006 Jun; 8(6):679-89. PubMed ID: 16570242
[TBL] [Abstract][Full Text] [Related]
24. Oncolytic adenoviral therapy for glioblastoma multiforme.
Sonabend AM; Ulasov IV; Han Y; Lesniak MS
Neurosurg Focus; 2006 Apr; 20(4):E19. PubMed ID: 16709024
[TBL] [Abstract][Full Text] [Related]
25. A novel attenuated replication-competent adenovirus for melanoma therapy.
Peter I; Graf C; Dummer R; Schaffner W; Greber UF; Hemmi S
Gene Ther; 2003 Apr; 10(7):530-9. PubMed ID: 12646858
[TBL] [Abstract][Full Text] [Related]
26. Tumor-specific therapeutic effect induced by an oncolytic adenoviral vector containing heat shock protein 70 and prodrug activation genes.
Liu Y; Ye T; Sun D; Maynard J; Deisseroth A
Gene Ther; 2006 Aug; 13(16):1235-43. PubMed ID: 16617300
[TBL] [Abstract][Full Text] [Related]
27. Oncolytic adenoviral vector carrying the cytosine deaminase gene for melanoma gene therapy.
Liu Y; Deisseroth A
Cancer Gene Ther; 2006 Sep; 13(9):845-55. PubMed ID: 16710344
[TBL] [Abstract][Full Text] [Related]
28. Inter-patient variation in efficacy of five oncolytic adenovirus candidates for ovarian cancer therapy.
Lam JT; Kanerva A; Bauerschmitz GJ; Takayama K; Suzuki K; Yamamoto M; Bhoola SM; Liu B; Wang M; Barnes MN; Alvarez RD; Siegal GP; Curiel DT; Hemminki A
J Gene Med; 2004 Dec; 6(12):1333-42. PubMed ID: 15493039
[TBL] [Abstract][Full Text] [Related]
29. Insulated hsp70B' promoter: stringent heat-inducible activity in replication-deficient, but not replication-competent adenoviruses.
Rohmer S; Mainka A; Knippertz I; Hesse A; Nettelbeck DM
J Gene Med; 2008 Apr; 10(4):340-54. PubMed ID: 18265421
[TBL] [Abstract][Full Text] [Related]
30. Identification of the transcriptional regulatory sequences of human calponin promoter and their use in targeting a conditionally replicating herpes vector to malignant human soft tissue and bone tumors.
Yamamura H; Hashio M; Noguchi M; Sugenoya Y; Osakada M; Hirano N; Sasaki Y; Yoden T; Awata N; Araki N; Tatsuta M; Miyatake SI; Takahashi K
Cancer Res; 2001 May; 61(10):3969-77. PubMed ID: 11358814
[TBL] [Abstract][Full Text] [Related]
31. The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapy.
Barker SD; Coolidge CJ; Kanerva A; Hakkarainen T; Yamamoto M; Liu B; Rivera AA; Bhoola SM; Barnes MN; Alvarez RD; Curiel DT; Hemminki A
J Gene Med; 2003 Apr; 5(4):300-10. PubMed ID: 12692864
[TBL] [Abstract][Full Text] [Related]
32. Restricted expression of an adenoviral vector encoding Fas ligand (CD95L) enhances safety for cancer gene therapy.
Aoki K; Akyürek LM; San H; Leung K; Parmacek MS; Nabel EG; Nabel GJ
Mol Ther; 2000 Jun; 1(6):555-65. PubMed ID: 10933980
[TBL] [Abstract][Full Text] [Related]
33. Improved glioblastoma treatment with Ad5/35 fiber chimeric conditionally replicating adenoviruses.
Hoffmann D; Meyer B; Wildner O
J Gene Med; 2007 Sep; 9(9):764-78. PubMed ID: 17640083
[TBL] [Abstract][Full Text] [Related]
34. Potential adenovirus-mediated gene therapy of glioma cancer.
Fu YJ; Du J; Yang RJ; Yin LT; Liang AH
Biotechnol Lett; 2010 Jan; 32(1):11-8. PubMed ID: 19784809
[TBL] [Abstract][Full Text] [Related]
35. Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter.
Zhu ZB; Makhija SK; Lu B; Wang M; Kaliberova L; Liu B; Rivera AA; Nettelbeck DM; Mahasreshti PJ; Leath CA; Yamamoto M; Alvarez RD; Curiel DT
Gene Ther; 2004 Apr; 11(7):645-8. PubMed ID: 15029227
[TBL] [Abstract][Full Text] [Related]
36. Local tumour irradiation enhances the anti-tumour effect of a double-suicide gene therapy system in a murine glioma model.
Desaknai S; Lumniczky K; Esik O; Hamada H; Safrany G
J Gene Med; 2003 May; 5(5):377-85. PubMed ID: 12731086
[TBL] [Abstract][Full Text] [Related]
37. Intratumoral gene therapy of malignant brain tumor in a rat model with angiostatin delivered by adeno-associated viral (AAV) vector.
Ma HI; Lin SZ; Chiang YH; Li J; Chen SL; Tsao YP; Xiao X
Gene Ther; 2002 Jan; 9(1):2-11. PubMed ID: 11850717
[TBL] [Abstract][Full Text] [Related]
38. Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas.
Lun X; Senger DL; Alain T; Oprea A; Parato K; Stojdl D; Lichty B; Power A; Johnston RN; Hamilton M; Parney I; Bell JC; Forsyth PA
J Natl Cancer Inst; 2006 Nov; 98(21):1546-57. PubMed ID: 17077357
[TBL] [Abstract][Full Text] [Related]
39. Glioma/glioblastoma-specific adenoviral gene expression using the nestin gene regulator.
Kurihara H; Zama A; Tamura M; Takeda J; Sasaki T; Takeuchi T
Gene Ther; 2000 Apr; 7(8):686-93. PubMed ID: 10800092
[TBL] [Abstract][Full Text] [Related]
40. Improvement of antitumor activity by gene amplification with a replicating but nondisseminating adenovirus.
Bourbeau D; Lau CJ; Jaime J; Koty Z; Zehntner SP; Lavoie G; Mes-Masson AM; Nalbantoglu J; Massie B
Cancer Res; 2007 Apr; 67(7):3387-95. PubMed ID: 17409449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
